GE HealthCare Technologies Inc.
NASDAQ Global SelectCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Peter J. Arduini
- Full Time Employees
- 54,000
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Address
- 500 West Monroe Street Chicago IL United States of America 60661
- IPO Date
- Dec 15, 2022
- CIK
- 0001932393
- Website
- gehealthcare.com
- Similar Companies
- Business
- GE HealthCare Technologies Inc. specializes in the design, production, and global distribution of advanced products, extensive services, and integrated digital platforms aimed at patient diagnostics, therapeutic interventions, and ongoing monitoring across numerous international regions. The organization structures its operations into four distinct divisions: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging division delivers sophisticated molecular imaging, computed tomography (CT), magnetic resonance (MR), image-guided therapy, and X-ray systems, alongside specialized offerings for women's health screening. The Ultrasound division offers solutions for the detection, assessment, treatment, and continuous oversight of various conditions through applications in radiology, primary care, cardiovascular health, women’s health, and handheld point-of-care devices, also incorporating surgical visualization and guidance products with AI-enabled productivity tools. The Patient Care Solutions division is dedicated to furnishing medical devices, essential consumables, supportive services, and intelligent digital tools for patient monitoring, anesthesia delivery and respiratory management, diagnostic cardiology, and maternal and infant care. The Pharmaceutical Diagnostics division supplies a range of diagnostic agents, including contrast media for CT, angiography, X-ray, and MR scans, as well as single-photon emission computed tomography and positron emission tomography, to the radiology and nuclear medicine sectors. This segment also provides pharmaceuticals administered prior to imaging to enhance tissue visibility and molecular imaging agents, which are radiopharmaceuticals with radioisotopes used for diagnostic scans. The company was established as a corporate entity in 2022 and maintains its primary corporate offices in Chicago, Illinois. In a significant recent development, the company has agreed to acquire Intelerad, a medical imaging software provider, for $2.3 billion, a move set to substantially enhance its cloud-based and AI-enabled imaging solutions, particularly expanding its reach into outpatient and teleradiology markets. This acquisition is expected to accelerate GE HealthCare's transition to a software-as-a-service (SaaS) business model and significantly boost its recurring revenue.
GEHC or LMAT: Which Is the Better Value Stock Right Now?
GE HealthCare (GEHC) Upgraded to Buy: Here's What You Should Know
GE HealthCare Technologies (GEHC) Just Overtook the 200-Day Moving Average
Here's Why GE HealthCare Technologies (GEHC) is a Strong Momentum Stock
GE HealthCare: Strong Orders, Innovation Pipeline, And PCS Recovery Point To Growth Inflection
Why GE HealthCare Technologies (GEHC) is a Top Value Stock for the Long-Term
GE HealthCare expands the LOGIQ e ultrasound platform with new LOGIQ e family
GE HealthCare expands breast imaging portfolio with Invenia ABUS Prime and launch of ABUS StreamVue
GE HealthCare Technologies Inc. (GEHC) Shareholders Who Lost Money - Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
Securities Fraud Investigation Into GE HealthCare Technologies Inc. (GEHC) Continues - Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Fi
Securities Fraud Investigation Into GE HealthCare Technologies Inc. (GEHC) Continues - Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
Securities Fraud Investigation Into GE HealthCare Technologies Inc. (GEHC) Continues - Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
Securities Fraud Investigation Into GE HealthCare Technologies Inc. (GEHC) Continues - Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
GE HealthCare Technologies Inc. (GEHC) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
GE HealthCare: Strong Demand, Weak Execution - Why The Backlog Matters More (Rating Upgrade)
GE HealthCare Technologies (NASDAQ:GEHC) Shares Gap Up After Better-Than-Expected Earnings
GEHC Q2 Earnings & Revenues Beat Estimates, Stock Up in Pre-Market
GE HealthCare Technologies Inc. (GEHC) Q2 2026 Earnings Call Transcript
Here's Why GE Healthcare Shares Popped Higher Today
Stocks Retreat as Middle East Hostilities Return